Correlation Between Biotechnology Fund and Sp 500

Can any of the company-specific risk be diversified away by investing in both Biotechnology Fund and Sp 500 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Fund and Sp 500 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Biotechnology Fund Class and Sp 500 Fund, you can compare the effects of market volatilities on Biotechnology Fund and Sp 500 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Fund with a short position of Sp 500. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Fund and Sp 500.

Diversification Opportunities for Biotechnology Fund and Sp 500

-0.39

Correlation Coefficient

Biotechnology Fund  Sp 500

Very good diversification

The 3 months correlation between Biotechnology and RYSOX is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Fund Class and Sp 500 Fund in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sp 500 Fund and Biotechnology Fund is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Fund Class are associated (or correlated) with Sp 500. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sp 500 Fund has no effect on the direction of Biotechnology Fund i.e., Biotechnology Fund and Sp 500 go up and down completely randomly.

Pair Corralation between Biotechnology Fund and Sp 500

Assuming the 90 days horizon Biotechnology Fund Class is expected to under-perform the Sp 500. In addition to that, Biotechnology Fund is 1.55 times more volatile than Sp 500 Fund. It trades about -0.02 of its total potential returns per unit of risk. Sp 500 Fund is currently generating about 0.2 per unit of volatility. If you would invest  8,463  in Sp 500 Fund on September 4, 2024 and sell it today you would earn a total of  801.00  from holding Sp 500 Fund or generate 9.46% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.44%
Values	Daily Returns

Biotechnology Fund Class  vs.  Sp 500 Fund

Biotechnology Fund Class

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Biotechnology Fund Class has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong technical and fundamental indicators, Biotechnology Fund is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Sp 500 Fund

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Sp 500 Fund are ranked lower than 15 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, Sp 500 may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Biotechnology Fund and Sp 500

The main advantage of trading using opposite Biotechnology Fund and Sp 500 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Fund position performs unexpectedly, Sp 500 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sp 500 will offset losses from the drop in Sp 500's long position.

The idea behind Biotechnology Fund Class and Sp 500 Fund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.